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A ROLE FOR INTERLEUKINS IN THE RAPID PROGRESSION OF
OSTEOARTHRITIS IN ALKAPTONURIA
A. Taylor y, M. Bukhari z, J. Mistry y. y Lancaster Univ., Lancaster, United
Kingdom; zUniv. Hosp. of Morecambe Bay NHS Fndn. Trust, Lancaster,
United Kingdom
Purpose: Alkaptonuria (AKU) is a rare autosomal recessive disorder
of tyrosine metabolism which causes rapidly progressing, early
onset osteoarthritis (OA). The diseases results from absence of the
enzyme homogentisate 1,2 dioxygenase, this enzyme breaks down
homogentisic acid (HGA). Levels of HGA are elevated systemically
from birth and over time HGA undergoes polymerisation, a process
called ochronosis. Ochronosis occurs predominantly in weight
bearing cartilages in hips, knees and intervertebral discs where it
causes ochronotic osteoarthropathy. Research into AKU has dem-
onstrated that focal change within cartilage is required to allow
ochronosis to occur; quickly followed by progression to devastating
ochronotic osteoarthropathy. The exact change that occurs within
the cartilage matrix that initiates the pigmentation process is
unknown. One potential candidate is trauma or damage resulting in
local inﬂammation and subsequent pigmentation. Our aim is to
examine the effect of both pro- and anti-inﬂammatory interleukins;
IL-1B, IL-6 and IL-10 respectively, on pigmentation (ochronosis) and
cell viability in an in vitro model of ochronotic osteoarthropathy in
AKU
Methods: C20 chondrosarcoma cells were seeded into 24 well plates
and cultured for 21 days in medium under the following conditions:
control, HGA, IL-1B or IL-6 or IL-10, HGAþIL-1B. Reagents were added to
medium at 0.33M for HGA and 1ng/ml for IL-1, 6 and 10. Medium was
changed every 3rd day. Cultures (n ¼ 6) for histological examination
were ﬁxed and then stained with schmorl’s reagent and nuclear fast red
to highlight pigmentation and allow quantiﬁcation. The effect of
reagents on cell viability was assessed by trypan blue assay. Statistical
analysis consisted of analysis of variance and differences between
groups was determined by Newman-Keuls post-test, all performed
using Graphpad Prism software
Results: C20 cultures treated with HGA (solely or in combination
with IL’s) demonstrated highly signiﬁcant increases in the number of
pigment deposits compared to control and IL cultures (p<0.001).
When comparing HGA solely against HGA in combination with IL-1,
-6 or -10 there were no signiﬁcant differences between groups.
Analysis of cell viability with IL-1 demonstrated that all culture
conditions showed a highly signiﬁcant decrease in cell number
compared to control (p<0.001). There was no signiﬁcance between
control and IL-1 alone. C20 cells cultured in HGA alone showed a
highly signiﬁcant decrease in cell number compared to HGAþIL-1.
Analysis of cultures with Il-6 showed that HGA and HGA þ Il-6 both
showed a highly signiﬁcant decrease compared to control (p<0.001).
Cells cultured in IL-6 alone showed no difference compared to con-
trol. C20 cells cultured in HGAþIL-6 showed a highly signiﬁcant
decrease in cell number compared to IL-6 alone (p<0.001), but no
difference to HGA alone. C20 cells cultured with HGA and HGAþIL-10
both showed a highly signiﬁcant decrease in cell numbers compared
to control. Cultures of HGAþIL-10 showed a highly signiﬁcant
decrease in cell numbers compared to IL-10 alone (p<0.001), but no
difference when compared to HGA alone. There was no difference
between HGA and HGAþIL-10
Conclusions: We demonstrate that addition of interleukins alongside
HGA does not appear to have an effect on the number of pigment
deposits compared to HGA alone. This suggests that the presence of
interleukins alongside HGA does not produce more pigmentation.
However the interleukins do appear to have an effect on cell viability,
most interestingly the addition of IL-1 alongside HGA does not appear
to be as detrimental to cell number as HGA alone. This may be why the
arthropathy in AKU is much earlier onset and rapid in progression than
that in OA. Also of interest is that anti-inﬂammatory interleukins do
not appear to reduce the decrease in cell number when used in
combination with HGA. In summary these results are the ﬁrst to
examine the combination of HGA and interleukins in the arthropathy
of AKU and the results suggest that the presence of interleukins does
not cause more pigmentation but they do appear to have a detrimental
effect on the number of cells present and as such may be a factor in
altering the extracellular milieu and promoting the degeneration
process.92
THE IMPORTANCE OF MESENCHYMAL STEM CELL DONOR’S AGE FOR
CARTILAGE ENGINEERING
Y. Li y, N. Charif y, D. Mainard y,z, J-F. Stoltz y,z, N. de Isla y. yCNRS UMR
7365, Vandoeuvre, France; zNancy Hosp., Nancy, France
In 1994, Brittber et coll. showed that cultured autologous chondrocytes
could be used to repair deep cartilage defects of the knee joint. But,
several problems are observed due to the differentiation of chon-
drocytes in culture leading to ﬁbrocartilage formation. More recently,
the use of bone marrow mesenchymal stem cells (BM-MSC) in cartilage
engineering has been used. As hinted by the role of stem cell senescence
and dysfunction in natural aging, donor or patient age will be a critical
factor that must be accounted for in clinical and laboratory evaluations
of bone marrow mesenchymal stem cell based technology.We eval-
uated in vitro chondrogenic differentiation of bone marrow mesen-
chymal stem cells in function of donor age and passage in culture. The
objective of such a study design was to provide a controlled analysis of
two variables (age and passage) and possible interaction between these
crucial factors in developing adult stem cell based therapeutics and for
which no consensus exists regarding their role in MSC differentiation.
Materials and Methods: Mesenchymal stem cells were obtained from
bonemarrow from human donors of different ages (n¼ 18, 3 to 85 years
old, mean age 49  27). Cells were isolated by plastic adherence (5 104
mononuclear cells/cm2) and cultured in a-MEMwith 10% SVF. After two
weeks cells were detached from culture ﬂasks and replated at 1000
cells/cm2. Then cells were passaged every two weeks. At each passage,
cells were counted, clonogenicity was tested by a colony forming unit
test and phenotypewas veriﬁed by ﬂow cytometry for the expression of
several markers (CD90, CD73, CD105, CD44, CD45, CD34, HLA-DR).
Chondrogenic potential was assayed after passage 1 and 4/5 using
speciﬁc differentiation media containing TGF-b. 2.5 x 105 cells were
used to form each chondrogenic pellet. After 28 days, Gene expression
of chondrogenic markers was evaluated by qPCR and matrix synthesis
by histology and alcian blue staining. Quantiﬁcation of staining areawas
performed by using ImageJ.
Results: Our study has revealed differences between proliferation
capacities of BM-MSC in function of donor’s age. Cells from old donors
proliferate slowly than cells from young donors and become senescent
after 4 or 5 passages. Two groups of donors have been deﬁned according
to proliferation capacity (less than 40 years old and over 40 years old).
Phenotype, clonogenicity and chondrogenic differentiation was studied
in the two groups. While cells expressed mesenchymal markers (CD90,
CD44, CD73, CD105) and did not expressed HLA-DR, CD45 or CD34, no
differences were observed in the expression level of the markers
according to donor’s age.
Clonogenicity was inceased for cells coming from young donors, both at
number or size levels. At the same time, young donors cells were
characterized by high level expression of type 2 collagen, aggrecan and
sox-9 genes after chondrogenic differentiationwhile cells from the> 40
years group showed a poor chondrogenic differentiation. Similar results
were observed at the matrix synthesis levels after alcian blue staining.
Cells from late passages showed decresed differentiation compared
with cells from early passages. However, at early passages, cells from
young donors presented a great differentiation potential than cells from
aged donors.
Conclusions: This study shows that differences on proliferation and
chondrogenic differentiation exist between mesenchymal stem cells
isolated from bone marrow obtained in young and old donors. These
results could be considered in the choice of MSC for cartilage tissue
engineering. The proliferation capacity of cells and their clonogenicity
are good parameters to rapidly estimate cell quality.
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LONGITUDINAL CHANGE IN OBJECTIVELY MONITORED STEPS/DAY
OVER 2-YEARS IN MIDDLE- TO OLDER-AGE ADULTS WITH OR AT
RISK OF KNEE OA: THE MOST STUDY
D.K. White y, C. Tudor-Locke z, Y. Zhang y, D. Felson y, K. Gross y,
M. Nevitt x, C.E. Lewis k, J. Torner{, T. Neogi y. yBoston Univ., Boston, MA,
USA; z Pennington BioMed. Reserach Ctr., Baton Rouge, LA, USA; xUCSF, San
Francisco, CA, USA; kUniv. Alabama Brimingham, Birmingham, AL, USA;
{Univ. of Iowa, Iowa City, IA, USA
Purpose: Maintaining an active lifestyle throughout the lifespan con-
fers a broad spectrum of health beneﬁts, including protection against
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S62the development of functional limitation and disability. Such effects are
highly relevant for people with knee OA, since knee OA is a leading
cause of functional limitation and disability in older adults. Cross-sec-
tional studies have shown that levels of physical activity progressively
drop across higher age categories, but have not accounted for potential
secular trends. How quickly this decline may occur is not known, nor
whether knee OA and related knee pain actually affect walking activity
patterns over time. Longitudinal data are needed to determine the
extent to which physical activity may change over time within indi-
viduals, and understand what factors may inﬂuence such change. We
therefore describe the ﬁrst objectively measured longitudinal walking
activity assessment over a two-year period in a large prospective cohort
of people with or at risk of knee OA.
Methods: Steps/day over 7-days were objectively measured with a
monitor at 60-months (baseline) and again at 84-months (i.e., 2 years
later) in the Multicenter Osteoarthritis (MOST) study, a longitudinal
prospective cohort of older adults with or at risk of knee OA. We cal-
culated change in steps/day over 2 years, and stratiﬁed by categories of
age, sex, obesity, depressive symptoms, radiographic knee OA, (ROA)
and knee pain. We evaluated the relation of these factors to change in
steps/day using linear regression adjusting for potential confounders.
Results: The 1,318 participants (age 66.9  7.7, 59% women, BMI 30.6 
5.9) who had analyzable data from their monitor walked 7317 steps/day
at baseline. Steps/day decreased with higher age categories, with those
over75years of agewalking2614 fewer steps/daycomparedwith those<
60 years of age after adjustment for potential confounders, which rep-
resents approximately 26 mins less walking/day. Study participants who
were obese and who had depressive symptoms walked 2251 and 517
fewer adjusted steps/day at baseline, respectively, compared with their
counterparts. The youngest obese subjects walked a similar amount as
the non-obese oldest adults (see Figure). From baseline to the two-year
follow-up, walking declined only slightly by 129 steps/day in the overall
sample. In general, change in steps/day over two years were minor and
didnotmeet statistical signiﬁcance. Inparticular, havingROAorkneepain
was not associated with a decline in walking over 2 years. However,
participantswithdepressive symptomswalked520 feweradjusted steps/
day over two-years compared with their non-depressed counterparts
(95% CI [-917, -123]), which represents 5 mins less walking/day.
Conclusions: This study is the largest cohort to date with longitudinal
changes in objectively measured physical activity. Overall there was
little decline in walking activity over a 2-year period, indicating that
declines in activity with aging occur over a longer timeframe. Further,
we did not ﬁnd radiographic disease or knee pain to result in decline in
physical activity over a 2-year follow up, contrary to the anecdotal
expectation. Depressive symptoms were the only factor found to be
signiﬁcantly associated with decline in walking activity over 2 years. Of
note, obese participants were already walking at levels similar to their
non-obese counterparts that were >15 years older. Thus, many obese
individuals were engaging in minimal walking activity to begin with,
perhaps reﬂecting the minimal activity needed to address instrumental
activities of daily living. This minimal walking activity at baseline left
little room for further decline (i.e., ﬂoor effect), and suggests that their
decline in physical activity occurred much earlier in life.Figure. Change. in steps/day across age-categories among obese and non-
obese study participants94
POST TRANSCRIPTIONAL GENE REGULATION IN AGEING CARTILAGE
AND CHONDROCYTES
M.J. Peffers, R. Fentom, S.R. Tew, P.D. Clegg. Univ. of Liverpool, Neston,
United Kingdom
Purpose: Ageing presents huge challenges for society because whilst
life span increases, the quality of life faced by individuals in old age is
often poor. Articular cartilage is susceptible to age related diseases, such
as osteoarthritis (OA). In recent RNASeq studies we demonstrated sig-
niﬁcant differences in expression of a number of genes related to car-
tilage extracellular matrix, proteases, and signalling in non-pathological
ageing. One important tier in gene regulation is mRNA stability at the
post-transcriptional level as steady-state mRNA levels are established
by both their rate of transcription and decay. In chondrocytes the extent
and nature of post-transcriptional gene control is still poorly under-
stood and no studies have examined how post-transcriptional regu-
lation of cartilage speciﬁc genes might vary in ageing. The primary
objective of this study was to determine the role of mRNA decay in post-
transcriptional gene regulation in ageing equine chondrocytes. The
secondary objective was to compare the decay results of explant studies
in parallel to chondrocyte studies in order to assess the effect of altered
chondrocyte phenotype; a known response of chondrocytes to removal
from their matrix.
Methods: Equine articular cartilage from the entire surface meta-
carpophalangeal joints was harvested from young (n ¼ 3) and old (n ¼
4) horses and split into explant and isolated primary chondrocyte work
ﬂows for each donor. The explants and chondrocytes were subjected to
actinomycin D chase experiment. The explants or chondrocytes were
harvested at time points over a 5 hour period and total RNA extracted.
Reverse transcription and quantitative real-time PCR (qPCR) was used
to measure RNA decay of collagen type1 alpha-1 (COL1A1), collagen
type 2 alpha-1 (COL2A1), runt-related transcription factor 2 (RUNX2),
dickkopf WNT signalling pathway inhibitor 1 (DKK1), a disintegrin and
metalloproteinase with thrombospondin motifs 5 (ADAMTS5), hyalur-
onan synthase 2 (HAS2) and ﬁbroblast growth factor 2 (FGF2) mRNA in
the cell and explant cultures. For all genes Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) mRNA was used as a normalisation factor
following identiﬁcation of its stability. Statistical analysis was under-
taken following normality testing using ANOVA in SPSS.
Results: Although we identiﬁed that actinomycin D did prevent tran-
scription in explant culture as demonstrated by a reduction in gene
expressionwith time, there was no change in transcript decay for any of
the genes in explant studies with age. We hypothesise that when
chondrocytes are removed from their matrix they de-differentiate and
so behave differently to chondrocytes in-situ. There was a signiﬁcant
increase in the half-life of the COL2A1 (p¼ 0.007) in older chondrocytes
compared to young chondrocytes (ﬁgure 1) and a trend in DKK1 (p ¼
0.07) and ADAMTS5 (p ¼ 0.07). In older donors there was a signiﬁcant
increase in RNA stability in chondrocytes compared to explants for
COL2A1 (p ¼ 0.013) and HAS2 (p ¼ 0.022).
